Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript

AXSM earnings call for the period ending March 31, 2024.

Related Keywords

, Darren Opland , Herriot Tabuteau , Marc Goodman Leerink , Jason Gerberry , Nick Pizzie , Mark Jacobson , David Amsellem Piper Sandler , Ram Selvaraju , Vikram Purohit , Joel Beatty , Charles Duncan , Graig Suvannavejh , Yatin Suneja , Vikram Purohit Morgan Stanley , Marc Goodman , Myles Minter , David Amsellem , Avantika Joshi Mizuho , William Blair , Yatin Suneja Guggenheim , Piper Sandler , Joon Lee , Myles Minter William Blair , Troy Langford , Joon Lee Truist , Charles Duncan Cantor Fitzgerald , Matt Kaplan Ladenburg Thalmann , Leonid Timashev , David Hoang , David Hoang Citi , Matt Kaplan , America Merrill Lynch , Exchange Commission , Ladenburg Thalmann , Company Analyst , Morgan Stanley , Narcolepsy Network , Corporate Communications , Jason Gerberry Bank , Cantor Fitzgerald , Axsome Therapeutics , Ari Maizel , Axsome Therapeutic , Vice President , Change Healthcare , Yash Verma , Chief Executive , Leerink Partners , Guggenheim Partners , Truist Securities , Mizuho Securities ,